High Flow Nasal Cannula Therapy in the Emergency Department: Main Benefits in Adults, Pediatric Population and against COVID-19: A Narrative Review
This review aims to summarize the literature’s main results about high flow nasal cannula therapy (HFNC) HFNC benefits in the Emergency Department (ED) in adults and pediatrics, including new Coronavirus Disease (COVID-19). HFNC has recently been established as the usual treatment in the ED to provi...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karolinum Press
2022-12-01
|
| Series: | Acta Medica |
| Online Access: | https://actamedica.lfhk.cuni.cz/65/2/0045/ |
| _version_ | 1811309581022789632 |
|---|---|
| author | Eduardo Esteban-Zubero Cristina García-Muro Moisés Alejandro Alatorre-Jiménez Vickramjeet Johal Carlos Arturo López-García Alejandro Marín-Medina |
| author_facet | Eduardo Esteban-Zubero Cristina García-Muro Moisés Alejandro Alatorre-Jiménez Vickramjeet Johal Carlos Arturo López-García Alejandro Marín-Medina |
| author_sort | Eduardo Esteban-Zubero |
| collection | DOAJ |
| description | This review aims to summarize the literature’s main results about high flow nasal cannula therapy (HFNC) HFNC benefits in the Emergency Department (ED) in adults and pediatrics, including new Coronavirus Disease (COVID-19). HFNC has recently been established as the usual treatment in the ED to provide oxygen support. Its use has been generalized due to its advantages over traditional oxygen therapy devices, including decreased nasopharyngeal resistance, washing out of the nasopharyngeal dead space, generation of positive pressure, increasing alveolar recruitment, easy adaptation due to the humidification of the airways, increased fraction of inspired oxygen and improved mucociliary clearance. A wide range of pathologies has been studied to evaluate the potential benefits of HFNC; some examples are heart failure, pneumonia, chronic pulmonary obstructive disease, asthma, and bronchiolitis. The regular use of this oxygen treatment is not established yet due to the literature’s controversial results. However, several authors suggest that it could be useful in several pathologies that generate acute respiratory failure. Consequently, the COVID-19 irruption has generated the question of HFNC as a safety and effective treatment. Our results suggested that HFNC seems to be a useful tool in the ED, especially in patients affected by acute hypoxemic respiratory failure, acute heart failure, pneumonia, bronchiolitis, asthma and acute respiratory distress syndrome in patients affected by COVID-19. Its benefits in hypercapnic respiratory failure are more discussed, being only observed benefits in patients with mild-moderate disease. These results are based in clinical as well as cost-effectiveness outcomes. Future studies with largest populations are required to confirm these results as well as establish a practical guideline to use this device. |
| first_indexed | 2024-04-13T09:43:43Z |
| format | Article |
| id | doaj.art-7ee8022c78524bc0ba464e5798e47373 |
| institution | Directory Open Access Journal |
| issn | 1805-9694 |
| language | English |
| last_indexed | 2024-04-13T09:43:43Z |
| publishDate | 2022-12-01 |
| publisher | Karolinum Press |
| record_format | Article |
| series | Acta Medica |
| spelling | doaj.art-7ee8022c78524bc0ba464e5798e473732022-12-22T02:51:49ZengKarolinum PressActa Medica1805-96942022-12-01652455210.14712/18059694.2022.17High Flow Nasal Cannula Therapy in the Emergency Department: Main Benefits in Adults, Pediatric Population and against COVID-19: A Narrative ReviewEduardo Esteban-ZuberoCristina García-MuroMoisés Alejandro Alatorre-JiménezVickramjeet JohalCarlos Arturo López-GarcíaAlejandro Marín-MedinaThis review aims to summarize the literature’s main results about high flow nasal cannula therapy (HFNC) HFNC benefits in the Emergency Department (ED) in adults and pediatrics, including new Coronavirus Disease (COVID-19). HFNC has recently been established as the usual treatment in the ED to provide oxygen support. Its use has been generalized due to its advantages over traditional oxygen therapy devices, including decreased nasopharyngeal resistance, washing out of the nasopharyngeal dead space, generation of positive pressure, increasing alveolar recruitment, easy adaptation due to the humidification of the airways, increased fraction of inspired oxygen and improved mucociliary clearance. A wide range of pathologies has been studied to evaluate the potential benefits of HFNC; some examples are heart failure, pneumonia, chronic pulmonary obstructive disease, asthma, and bronchiolitis. The regular use of this oxygen treatment is not established yet due to the literature’s controversial results. However, several authors suggest that it could be useful in several pathologies that generate acute respiratory failure. Consequently, the COVID-19 irruption has generated the question of HFNC as a safety and effective treatment. Our results suggested that HFNC seems to be a useful tool in the ED, especially in patients affected by acute hypoxemic respiratory failure, acute heart failure, pneumonia, bronchiolitis, asthma and acute respiratory distress syndrome in patients affected by COVID-19. Its benefits in hypercapnic respiratory failure are more discussed, being only observed benefits in patients with mild-moderate disease. These results are based in clinical as well as cost-effectiveness outcomes. Future studies with largest populations are required to confirm these results as well as establish a practical guideline to use this device.https://actamedica.lfhk.cuni.cz/65/2/0045/ |
| spellingShingle | Eduardo Esteban-Zubero Cristina García-Muro Moisés Alejandro Alatorre-Jiménez Vickramjeet Johal Carlos Arturo López-García Alejandro Marín-Medina High Flow Nasal Cannula Therapy in the Emergency Department: Main Benefits in Adults, Pediatric Population and against COVID-19: A Narrative Review Acta Medica |
| title | High Flow Nasal Cannula Therapy in the Emergency Department: Main Benefits in Adults, Pediatric Population and against COVID-19: A Narrative Review |
| title_full | High Flow Nasal Cannula Therapy in the Emergency Department: Main Benefits in Adults, Pediatric Population and against COVID-19: A Narrative Review |
| title_fullStr | High Flow Nasal Cannula Therapy in the Emergency Department: Main Benefits in Adults, Pediatric Population and against COVID-19: A Narrative Review |
| title_full_unstemmed | High Flow Nasal Cannula Therapy in the Emergency Department: Main Benefits in Adults, Pediatric Population and against COVID-19: A Narrative Review |
| title_short | High Flow Nasal Cannula Therapy in the Emergency Department: Main Benefits in Adults, Pediatric Population and against COVID-19: A Narrative Review |
| title_sort | high flow nasal cannula therapy in the emergency department main benefits in adults pediatric population and against covid 19 a narrative review |
| url | https://actamedica.lfhk.cuni.cz/65/2/0045/ |
| work_keys_str_mv | AT eduardoestebanzubero highflownasalcannulatherapyintheemergencydepartmentmainbenefitsinadultspediatricpopulationandagainstcovid19anarrativereview AT cristinagarciamuro highflownasalcannulatherapyintheemergencydepartmentmainbenefitsinadultspediatricpopulationandagainstcovid19anarrativereview AT moisesalejandroalatorrejimenez highflownasalcannulatherapyintheemergencydepartmentmainbenefitsinadultspediatricpopulationandagainstcovid19anarrativereview AT vickramjeetjohal highflownasalcannulatherapyintheemergencydepartmentmainbenefitsinadultspediatricpopulationandagainstcovid19anarrativereview AT carlosarturolopezgarcia highflownasalcannulatherapyintheemergencydepartmentmainbenefitsinadultspediatricpopulationandagainstcovid19anarrativereview AT alejandromarinmedina highflownasalcannulatherapyintheemergencydepartmentmainbenefitsinadultspediatricpopulationandagainstcovid19anarrativereview |